A detailed history of Nilsine Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Nilsine Partners, LLC holds 19,067 shares of JNJ stock, worth $2.78 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
19,067
Previous 19,170 0.54%
Holding current value
$2.78 Million
Previous $3 Billion 0.38%
% of portfolio
0.41%
Previous 0.46%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$155.22 - $162.74 $15,987 - $16,762
-103 Reduced 0.54%
19,067 $3.02 Billion
Q4 2023

Jan 24, 2024

SELL
$145.6 - $158.88 $352,643 - $384,807
-2,422 Reduced 11.22%
19,170 $3 Billion
Q3 2023

Nov 01, 2023

SELL
$155.75 - $174.48 $82,547 - $92,474
-530 Reduced 2.4%
21,592 $3.36 Billion
Q2 2023

Jul 21, 2023

BUY
$154.35 - $166.11 $55,411 - $59,633
359 Added 1.65%
22,122 $3.66 Billion
Q1 2023

May 10, 2023

BUY
$151.05 - $180.26 $3.29 Million - $3.92 Million
21,763 New
21,763 $3.37 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Nilsine Partners, LLC Portfolio

Follow Nilsine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nilsine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nilsine Partners, LLC with notifications on news.